References
  1. The Johns Hopkins University of Medicine. COVID-19 dashboard by the Center for Systems Science and Engineering at Johns Hopkins University. https://coronavirus.jhu.edu/map.html Date accessed: November 22, 2020
  2. Sanyaolu, A., Okorie, C., Marinkovic, A. et al.  Comorbidity and its Impact on Patients with COVID-19. SN Compr. Clin. Med.  2, 1069–1076 (2020). https://doi.org/10.1007/s42399-020-00363-4.
  3. Hasan Ejaz, Abdullah Alsrhani, Aizza Zafar, Humera Javed, Kashaf Junaid, Abualgasim E. Abdalla, Khalid O.A. Abosalif, Zeeshan Ahmed, Sonia Younas, COVID-19 and comorbidities: Deleterious impact on infected patients, Journal of Infection and Public Health. 2020;[Pre-print] DOI: 10.1016/j.jiph.2020.07.014 https://doi.org/10.1016/j.jiph.2020.07.014.
  4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
  5. Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 2010 Sep;47:193e9. doi: 10.1007/s00592-009-0109-4
  6. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell2020; 181 (2): 271–280. https://doi.org/10.1016/j.cell.2020.02.052.
  7. Fadini, G.P., Morieri, M.L., Longato, E. et al.  Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest . 2020; 43,  867–869. https://doi.org/10.1007/s40618-020-01236-2.
  8. Rimesh Pal, Sanjay K. Bhadada, COVID-19 and diabetes mellitus: An unholy interaction of two pandemics, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14(4): 513-517 https://doi.org/10.1016/j.dsx.2020.04.049.
  9. Hollstein, T., Schulte, D.M., Schulz, J. et al.  Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab  2,  1021–1024 (2020). https://doi.org/10.1038/s42255-020-00281-8.
  10. Hadil A A O, Eman S, Bashayer Zuhair A S, Anwar J. Diabetic Ketoacidosis and New Onset Diabetes Mellitus Precipitated by COVID-19 Infection. JOJ Case Stud. 2020; 11(3): 555815. DOI 10.19080/JOJCS.2020.11.555815.
  11. Thirunavukkarasu Sathish, Yingting Cao, Nitin Kapoor, Newly diagnosed diabetes in COVID 19 patients, Primary Care Diabetes, 10.1016/j.pcd.2020.08.014, (2020). https://doi.org/10.1002/jmv.26339
  12. Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series. Diabetes Res Clin Pract . 2020;166:108279. doi:10.1016/j.diabres.2020.108279.
  13. Rimesh Pal, Mainak Banerjee, Urmila Yadav, Sukrita Bhattacharjee, Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14(6): 1563-1569 https://doi.org/10.1016/j.dsx.2020.08.015.
  14. Armeni E, Aziz U, Qamar S, Nasir S, Nethaji C, Negus R, Beynon H.C, Bouloux P, Rosenthal M, Khan S, Yousseif A and Menon. Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series. Lancet Diabetes Endocrinol . 2020;8(8): 660-663. https://doi.org/10.1016/S2213-8587(20)30221-7.